相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cerebrospinal fluid biomarker results in relation to neuropathological dementia diagnoses
Hans Brunnstrom et al.
ALZHEIMERS & DEMENTIA (2010)
Development of an Ultra-Rapid Diagnostic Method Based on Heart-Type Fatty Acid Binding Protein Levels in the CSF of CJD Patients
Yuki Matsui et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2010)
Amyloid-β(1-42), Total Tau, and Phosphorylated Tau as Cerebrospinal Fluid Biomarkers for the Diagnosis of Alzheimer Disease
Cees Mulder et al.
CLINICAL CHEMISTRY (2010)
Total and phosphorylated tau protein as biological markers of Alzheimer's disease
Harald Hampel et al.
EXPERIMENTAL GERONTOLOGY (2010)
An unbiased, staged, multicentre, validation strategy for Alzheimer's disease CSF tau levels
A. Petzold et al.
EXPERIMENTAL NEUROLOGY (2010)
Differential levels of α-synuclein, β-amyloid42 and tau in CSF between patients with dementia with Lewy bodies and Alzheimer's disease
Kensaku Kasuga et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2010)
Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
Kaj Blennow et al.
NATURE REVIEWS NEUROLOGY (2010)
Ubiquitin as potential cerebrospinal fluid marker of Creutzfeldt-Jakob disease
Petra Steinacker et al.
PROTEOMICS (2010)
CSF biomarker profile and diagnostic value in vascular dementia
G. P. Paraskevas et al.
EUROPEAN JOURNAL OF NEUROLOGY (2009)
CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment
Niklas Mattsson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Formation and development of Lewy pathology: a critical update
Kurt A. Jellinger
JOURNAL OF NEUROLOGY (2009)
Diagnostic value of CSF protein profile in a Portuguese population of sCJD patients
Ines Esteves Baldeiras et al.
JOURNAL OF NEUROLOGY (2009)
Cerebrospinal fluid biomarkers in human genetic transmissible spongiform encephalopathies
Anna Ladogana et al.
JOURNAL OF NEUROLOGY (2009)
CSF phosphorylated tau in the diagnosis and prognosis of mild cognitive impairment and Alzheimer's disease: a meta-analysis of 51 studies
A. J. Mitchell
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2009)
Pattern of Tau forms in CSF is altered in progressive supranuclear palsy
B. Borroni et al.
NEUROBIOLOGY OF AGING (2009)
The diagnostic efficiency of biomarkers in sporadic Creutzfeldt-Jakob disease compared to Alzheimer's disease
Justyna Maria Czarna Bahl et al.
NEUROBIOLOGY OF AGING (2009)
Improved discrimination of autopsy-confirmed Alzheimer's disease (AD) from non-AD dementias using CSF P-tau181P
Karen Koopman et al.
NEUROCHEMISTRY INTERNATIONAL (2009)
A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking
C. E. Teunissen et al.
NEUROLOGY (2009)
The role of cerebrospinal fluid proteins as early diagnostic markers for sporadic Creutzfeldt-Jakob disease
Catherine Pennington et al.
NEUROSCIENCE LETTERS (2009)
A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's disease
N. A. Verwey et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2009)
Diagnostic value of CSF biomarker profile in frontotemporal lobar degeneration
Elisabeth Kapaki et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2008)
Cerebrospinal Fluid Biomarkers in Parkinson's Disease with Dementia and Dementia with Lewy Bodies
Lucilla Parnetti et al.
BIOLOGICAL PSYCHIATRY (2008)
Cerebrospinal fluid neurochemical phenotypes in vascular dementias: Original data and mini-review
Mirko Bibl et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2008)
Diagnostic performance of a CSF-biomarker panel in autopsy-confirmed dementia
Sebastiaan Engelborghs et al.
NEUROBIOLOGY OF AGING (2008)
Cerebrospinal fluid levels of tau phosphorylated at threonine 181 in patients with Alzheimer's disease and vascular dementia
Sabrina Ravaglia et al.
NEUROLOGICAL SCIENCES (2008)
Tau forms in CSF as a reliable biomarker for progressive supranuclear palsy
B. Borroni et al.
NEUROLOGY (2008)
CSF biomarkers in frontotemporal lobar degeneration with known pathology
H. Bian et al.
NEUROLOGY (2008)
Cerebrospinal fluid markers in Creutzfeldt-Jakob disease
Anders Skinningsrud et al.
FLUIDS AND BARRIERS OF THE CNS (2008)
Biomarkers for early detection of Alzheimer pathology
C. M. Clark et al.
NEUROSIGNALS (2008)
Diagnostic markers for diagnosing dementia with Lewy bodies: CSF and MIBG cardiac scintigraphy study
Kenji Wada-Isoe et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2007)
CSF neurofilament proteins in the differential diagnosis of dementia
D. de Jong et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2007)
Diagnostic accuracy of ELISA and xMAP technology for analysis of amyloid β42 and Tau proteins
Thierry S. M. Reijn et al.
CLINICAL CHEMISTRY (2007)
Evaluation of CSF-chlamydia pneumoniae, CSF-tau, and CSF-Abeta42 in Alzheimer's disease and vascular dementia
Boguslaw Paradowski et al.
JOURNAL OF NEUROLOGY (2007)
Serum heart-type fatty acid-binding protein and cerebrospinal fluid tau: Marker candidates for dementia with Lewy bodies
Brit Mollenhauer et al.
NEURODEGENERATIVE DISEASES (2007)
Total tau protein in cerebrospinal fluid and diffusion-weighted MRI as an early diagnostic marker for Creutzfeldt-Jakob disease
Katsuya Satoh et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2007)
Human transmissible spongiform encephalopathies in eleven countries:: diagnostic pattern across time, 1993-2002
Jesus de Pedro-Cuesta et al.
BMC PUBLIC HEALTH (2006)
CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease
Katharina Buerger et al.
BRAIN (2006)
CSF diagnosis of Alzheimer's disease and dementia with Lewy bodies
M. Bibl et al.
JOURNAL OF NEURAL TRANSMISSION (2006)
CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease
P. Sanchez-Juan et al.
NEUROLOGY (2006)
Neuropsychological and behavioural correlates of CSF biomarkers in dementia
S Engelborghs et al.
NEUROCHEMISTRY INTERNATIONAL (2006)
14-3-3 protein, total tau and phosphorylated tau in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease and neurodegenerative disease in Japan
K Satoh et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2006)
Total tau protein, phosphorylated tau (181p) protein, β-amyloid1-42, and β-amyloid1-40 in cerebrospinal fluid of patients with dementia with Lewy bodies
B Mollenhauer et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2006)
Raised CSF phospho-tau concentrations in variant Creutzfeldt-Jakob disease: diagnostic and pathological implications
CA Goodall et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2006)
Measurement of thirteen biological markers in CSF of patients with Alzheimer's disease and other dementias
I Blasko et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2006)
Analytical performance and clinical utility of the INNOTEST (R) PHOSPHO-TAU((181P)) assay for discrimination between Alzheimer's disease and dementia with Lewy bodies
Hugo Vanderstichele et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2006)
Dissociation between CSF total tau and tau protein phosphorylated at threonine 231 in Creutzfeldt-Jakob disease
K Buerger et al.
NEUROBIOLOGY OF AGING (2006)
Diagnosis and management of dementia with Lewy bodies - Third report of the DLB consortium
IG McKeith et al.
NEUROLOGY (2005)
Epidemiology and risk factors of dementia
WM van der Flier et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2005)
AD with subcortical white matter lesions and vascular dementia: CSF markers for differential diagnosis
A Stefani et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2005)
The diagnostic value of cerebrospinal fluid tau protein in dementing and nondementing neuropsychiatric disorders
GR Paraskevas et al.
JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY (2005)
Cerebrospinal fluid tau, Aβ1-42 and inflammatory cytokines in patients with Alzheimer's disease and vascular dementia
JP Jia et al.
NEUROSCIENCE LETTERS (2005)
Follow-up investigations in cerebrospinal fluid of patients with dementia with Lewy bodies and Alzheimer's disease
B Mollenhauer et al.
JOURNAL OF NEURAL TRANSMISSION (2005)
Cerebrospinal fluid profile in frontotemporal dementia and Alzheimer's disease
M Grossman et al.
ANNALS OF NEUROLOGY (2005)
Follow-up investigations of tau protein and S-100B levels in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease
L Cepek et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2005)
Real-time quantification of microRNAs by stem-loop RT-PCR
CF Chen et al.
NUCLEIC ACIDS RESEARCH (2005)
Differential diagnosis of 201 possible Creutzfeldt-Jakob disease patients
B Van Everbroeck et al.
JOURNAL OF NEUROLOGY (2004)
Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease - A comparative cerebrospinal fluid study
H Hampel et al.
ARCHIVES OF GENERAL PSYCHIATRY (2004)
Cerebrospinal fluid tau and β-amyloid -: How well do these biomarkers reflect autopsy-confirmed dementia diagnoses?
CM Clark et al.
ARCHIVES OF NEUROLOGY (2003)
Cerebrospinal fluid tau levels in Alzheimer's disease are elevated when compared with vascular dementia but do not correlate with measures of cerebral atrophy
P Schönknecht et al.
PSYCHIATRY RESEARCH (2003)
CSF markers for incipient Alzheimer's disease
K Blennow et al.
LANCET NEUROLOGY (2003)
Cerebrospinal fluid biochemical markers in early detection and in differential diagnosis of dementia disorders in routine clinical practice
L Parnetti et al.
NEUROLOGICAL SCIENCES (2003)
A prospective study of CSF markers in 250 patients with possible Creutzfeldt-Jakob disease
B Van Everbroeck et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2003)
Cerebrospinal fluid markers in dementia with Lewy bodies compared with Alzheimer disease
E Gómez-Tortosa et al.
ARCHIVES OF NEUROLOGY (2003)
CSF tau protein and β-amyloid (1-42) in Alzheimer's disease diagnosis:: discrimination from normal ageing and other dementias in the Greek population
E Kapaki et al.
EUROPEAN JOURNAL OF NEUROLOGY (2003)
Decreased cerebrospinal fluid acetylcholinesterase in patients with subcortical ischemic vascular dementia
A Wallin et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2003)
Phospho-tau/total tau ratio in cerebrospinal fluid discriminates Creutzfeldt-Jakob disease from other dementias
M Riemenschneider et al.
MOLECULAR PSYCHIATRY (2003)
Cerebrospinal fluid tissue transglutaminase as a biochemical marker for Alzheimer's disease
RM Bonelli et al.
NEUROBIOLOGY OF DISEASE (2002)
Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231
K Buerger et al.
ARCHIVES OF NEUROLOGY (2002)
Cerebrospinal fluid tau in dementia disorders: a large scale multicenter study by a Japanese study group
M Shoji et al.
NEUROBIOLOGY OF AGING (2002)
Levels of nonphosphorylated and phosphorylated tau in cerebrospinal fluid of Alzheimer's disease patients - An ultrasensitive bienzyme-substrate-recycle enzyme-linked Immunosorbent assay
YY Hu et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Measurement of laminins in the cerebrospinal fluid obtained from patients with Alzheimer's disease and vascular dementia using a modified enzyme-linked immunosorbent assay
K Matsuda et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2002)
Cerebrospinal fluid cytoskeleton proteins in patients with subcortical white-matter dementia
A Wallin et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2001)
Cerebrospinal fluid τ and β-amyloid(I-42) in dementia disorders
E Vanmechelen et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2001)
Neurofilament protein in cerebrospinal fluid:: A marker of white matter changes
M Sjögren et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2001)
Clinical and pathological diagnosis of Frontotemporal Dementia - Report of the work group on Frontotemporal Dementia and Pick's disease
GM McKhann et al.
ARCHIVES OF NEUROLOGY (2001)
Highly increased CSF tau protein and decreased β-amyloid (1-42) in sporadic CJD:: a discrimination from Alzheimer's disease?
E Kapaki et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2001)
Use of 14-3-3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt-Jakob disease
AJE Green et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2001)
Both total and phosphorylated tau are increased in Alzheimer's disease
M Sjögren et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2001)
Local and systemic GM-CSF increase in Alzheimer's disease and vascular dementia
E Tarkowski et al.
ACTA NEUROLOGICA SCANDINAVICA (2001)
Evaluation of CSF-tau and CSF-Aβ42 as diagnostic markers for Alzheimer disease in clinical practice
N Andreasen et al.
ARCHIVES OF NEUROLOGY (2001)
CSF phosphorylated tau is a possible marker for discriminating Alzheimer's disease from dementia with Lewy bodies
L Parnetti et al.
NEUROLOGICAL SCIENCES (2001)
Tau protein in cerebrospinal fluid from semantic dementia patients
C Andersen et al.
NEUROSCIENCE LETTERS (2000)
Tau protein isoforms, phosphorylation and role in neurodegenerative disorders
L Buée et al.
BRAIN RESEARCH REVIEWS (2000)
CSF levels of tau, beta-amyloid(1-42) and GAP-43 in frontotemporal dementia, other types of dementia and normal aging
M Sjogren et al.
JOURNAL OF NEURAL TRANSMISSION (2000)
Atypical and typical presentations of Alzheimer's disease: a clinical, neuropsychological, neuroimaging and pathological study of 13 cases
CJ Galton et al.
BRAIN (2000)
分享论文
